Osimertinib combined with bevacizumab for leptomeningeal...

  • Main
  • 2020 / 11
  • Osimertinib combined with bevacizumab for leptomeningeal...
Thoracic Cancer 2020 / 11

Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR ‐mutation non‐small cell lung cancer: A phase II single‐arm prospective clinical trial

Lu, Zhi‐qin, Cai, Jing, Wang, Xia, Wei, Jian‐ping, Zeng, Zhi‐min, Huang, Long, Liu, An‐wen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13738
Date:
November, 2020
File:
PDF, 431 KB
2020
Conversion to is in progress
Conversion to is failed